Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor stimulator. This innovative treatment holds significant hope for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide improves insulin secretion and suppresses glucagon release, leading to improved glucose control. Clinical trials have demons